ANTH Key Stats
- Hansen Medical Announces Appointment of Chris Lowe as Interim CEO; Bruce Barclay to Depart the Company noodls 02/10 16:45 ET
- Anthera Pharmaceuticals to Present at Leerink Swann, Cowen & Co., and BIO CEO Healthcare Conferences PR Newswire 01/30 16:42 ET
- FLG Partners Announces Chris Lowe as a New Partner Marketwired 01/28 13:07 ET
- ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers 12/23 06:01 ET
- Stock futures edge up after retail, claims data MarketWatch 12/12 09:23 ET
- Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference PR Newswire 11/27 17:00 ET
- Anthera Pharma (ANTH) Stock Drops Street Insider 11/19 10:46 ET
- Two Drugs, Designed To Help Patients, Actually Hurt Them 11/19 05:38 ET
- ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and 11/15 16:31 ET
- ANTHERA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report 11/14 16:15 ET
ANTH Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Anthera Pharmaceuticals is down 29.53% over the last year vs S&P 500 Total Return up 24.21%, Actelion up 102.5%, and GlaxoSmithKline up 30.48%.
Balance Sheet View Statement
Pro Ratings for ANTH
Pro Strategies Featuring ANTH
Did Anthera Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Headquarters Country: United States
- Headquarters State/Province: California
- Incorporation Country: United States
- Incorporation State/Province: Delaware
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company engaged in developing and commercializing products to treat autoimmune diseases.